Last 7 days
-3.3%
Last 30 days
-13.4%
Last 90 days
-10.7%
Trailing 12 Months
33.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-06 | AYERS JONATHAN W | gifted | - | - | -147,821 | - |
2023-09-06 | AYERS JONATHAN W | gifted | - | - | 147,821 | - |
2023-09-01 | Smith Martin Alexander | acquired | - | - | 19.00 | executive vice president |
2023-09-01 | AYERS JONATHAN W | gifted | - | - | -250 | - |
2023-09-01 | Smith Martin Alexander | sold (taxes) | -2,556 | 511 | -5.00 | executive vice president |
2023-08-31 | MAZELSKY JONATHAN JAY | acquired | 1,067,740 | 79.54 | 13,424 | president and ceo |
2023-08-31 | AYERS JONATHAN W | gifted | - | - | -1,250 | - |
2023-08-31 | MAZELSKY JONATHAN JAY | sold | -6,873,270 | 512 | -13,424 | president and ceo |
2023-08-29 | POLEWACZYK JAMES F | acquired | 2,438,480 | 144 | 16,909 | executive vice president |
2023-08-29 | POLEWACZYK JAMES F | sold | -11,696,400 | 510 | -22,909 | executive vice president |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Baystate Wealth Management LLC | added | 23.2 | 29,667 | 154,687 | 0.01% |
2023-09-21 | Jefferies Group LLC | new | - | 2,117,700 | 2,117,700 | 0.02% |
2023-09-20 | BARCLAYS PLC | added | 95.78 | 41,798,000 | 85,064,000 | 0.05% |
2023-09-14 | IMS Capital Management | reduced | -3.04 | -10,789 | 400,277 | 0.22% |
2023-09-12 | Farther Finance Advisors, LLC | added | 4.17 | 1,108 | 25,112 | -% |
2023-09-07 | ACADEMY CAPITAL MANAGEMENT INC/TX | reduced | -0.73 | -53,519 | 17,562,500 | 3.52% |
2023-09-07 | JAG CAPITAL MANAGEMENT, LLC | added | 3.43 | 131,637 | 3,531,680 | 0.41% |
2023-09-05 | Delos Wealth Advisors, LLC | unchanged | - | 2.00 | 503 | -% |
2023-08-30 | Western Wealth Management, LLC | unchanged | - | 4,684 | 1,094,360 | 0.09% |
2023-08-29 | Garde Capital, Inc. | unchanged | - | 1,000 | 309,000 | 0.03% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | fundsmith llp | 5.37% | 4,447,828 | SC 13G | |
Feb 14, 2023 | fundsmith llp | 5.37% | 4,447,828 | SC 13G | |
Feb 09, 2023 | vanguard group inc | 9.82% | 8,132,479 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 10.3% | 8,502,881 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 10.3% | 8,502,881 | SC 13G/A | |
Feb 10, 2022 | vanguard group inc | 9.34% | 7,923,466 | SC 13G/A | |
Jan 27, 2022 | blackrock inc. | 10.6% | 8,990,586 | SC 13G/A | |
Jan 25, 2022 | blackrock inc. | 10.6% | 8,990,586 | SC 13G/A | |
Sep 09, 2021 | blackrock inc. | 10.1% | 8,612,405 | SC 13G/A | |
Feb 12, 2021 | fundsmith llp | 4.95% | 4,226,428 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 08, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 06, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading | |
Sep 05, 2023 | 4 | Insider Trading | |
Aug 31, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 31, 2023 | 4 | Insider Trading | |
Aug 29, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 17, 2023 | 4 | Insider Trading | |
Aug 14, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 186.1B | 30.4B | -2.55% | -6.78% | 29.25 | 6.13 | -1.49% | 0.14% |
ABT | 169.6B | 40.2B | -6.64% | -2.43% | 32.87 | 4.22 | -11.68% | -39.67% |
MDT | 106.4B | 31.6B | -4.08% | -3.94% | 29.34 | 3.37 | 1.57% | -30.40% |
IDXX | 36.3B | 3.5B | -13.39% | 33.61% | 45.89 | 10.33 | 6.21% | 19.20% |
WST | 27.8B | 2.9B | -5.23% | 47.17% | 53.51 | 9.68 | -2.14% | -24.34% |
MID-CAP | ||||||||
PEN | 9.5B | 937.8M | -2.12% | 37.22% | 325.17 | 10.1 | 16.30% | 250.21% |
LNTH | 4.5B | 1.1B | -6.83% | -12.71% | 135.07 | 4.01 | 69.36% | 3.03% |
NEOG | 4.2B | 822.4M | -17.77% | 27.32% | -184 | 5.12 | 56.01% | -147.34% |
QDEL | - | - | -12.36% | -2.62% | - | - | - | - |
SMALL-CAP | ||||||||
VIVO | 1.5B | 301.6M | 2.29% | 56.91% | -550.1 | 4.93 | -3.75% | -104.51% |
HSKA | 1.2B | 254.9M | 2.45% | 31.18% | -62.25 | 4.89 | -1.22% | 15.74% |
CYRX | 664.8M | 240.7M | -6.95% | -50.26% | -15.57 | 2.76 | 4.82% | 85.44% |
AWH | 43.3M | 9.0M | 56.07% | -12.11% | -2.4 | 4.79 | 20.81% | 50.13% |
QTNT | 766.7K | 37.4M | -50.00% | -99.61% | -0.01 | 0.02 | -2.49% | 10.49% |
24.4%
21.5%
12.6%
5.8%
68.8%
38.5%
18.5%
Y-axis is the maximum loss one would have experienced if IDEXX Laboratories was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 2.4% | 3,514 | 3,431 | 3,367 | 3,340 | 3,309 | 3,274 | 3,215 | 3,135 | 3,047 | 2,858 | 2,707 | 2,591 | 2,475 | 2,457 | 2,407 | 2,351 | 2,291 | 2,252 | 2,213 | 2,170 | 2,117 |
Cost Of Revenue | 1.8% | 1,407 | 1,382 | 1,363 | 1,364 | 1,366 | 1,357 | 1,326 | 1,308 | 1,288 | 1,228 | 1,136 | - | - | - | 1,041 | - | - | - | 972 | 956 | 934 |
Gross Profit | 2.9% | 2,107 | 2,049 | 2,004 | 1,976 | 1,942 | 1,917 | 1,889 | 1,843 | 1,792 | 1,682 | 1,571 | 1,493 | 1,415 | 1,394 | 1,366 | 1,335 | 1,295 | 1,270 | 1,242 | 1,214 | 1,182 |
S&GA Expenses | 1.9% | 550 | 540 | 525 | 521 | 515 | 504 | 487 | 474 | 458 | 433 | 434 | 424 | 421 | 428 | 418 | 408 | 399 | 394 | 387 | 382 | 376 |
R&D Expenses | -29.6% | 183 | 259 | 255 | 257 | 249 | 164 | 161 | 154 | 152 | 146 | 141 | 138 | 134 | 135 | 133 | 128 | 123 | 120 | 118 | 117 | 115 |
EBITDA | -100.0% | - | 1,046 | 1,012 | 983 | 962 | 1,039 | 1,037 | 1,020 | 964 | 896 | 791 | 720 | 685 | 654 | 641 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.30* | 0.30* | 0.29* | 0.29* | 0.32* | 0.32* | 0.33* | 0.32* | 0.31* | 0.29* | 0.28* | 0.28* | 0.27* | 0.27* | - | - | - | - | - | - |
Interest Expenses | 4.8% | 48.00 | 46.00 | 40.00 | 34.00 | 30.00 | 29.00 | 30.00 | 30.00 | 31.00 | 33.00 | 33.00 | 33.00 | 32.00 | 30.00 | 31.00 | 32.00 | 34.00 | 34.00 | 35.00 | 36.00 | 37.00 |
Earnings Before Taxes | 13.0% | 1,001 | 886 | 860 | 839 | 823 | 904 | 903 | 888 | 833 | 765 | 662 | 593 | 562 | 534 | 522 | 521 | 497 | 478 | 458 | 440 | 423 |
EBT Margin | -100.0% | - | 0.26* | 0.26* | 0.25* | 0.25* | 0.28* | 0.28* | 0.28* | 0.27* | 0.27* | 0.24* | 0.23* | 0.23* | 0.22* | 0.22* | - | - | - | - | - | - |
Net Income | 13.2% | 791 | 699 | 679 | 670 | 664 | 735 | 745 | 757 | 728 | 674 | 582 | 498 | 460 | 437 | 428 | 423 | 407 | 390 | 377 | 330 | 307 |
Net Income Margin | -100.0% | - | 0.20* | 0.20* | 0.20* | 0.20* | 0.22* | 0.23* | 0.24* | 0.24* | 0.24* | 0.21* | 0.19* | 0.19* | 0.18* | 0.18* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 456 | 394 | 448 | 439 | 615 | 636 | 663 | 694 | 666 | 541 | 446 | 367 | 287 | 304 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 2.2% | 2,871 | 2,808 | 2,747 | 2,640 | 2,607 | 2,593 | 2,437 | 2,386 | 2,412 | 2,327 | 2,295 | 2,047 | 1,961 | 1,886 | 1,832 | 1,751 | 1,724 | 1,681 | 1,537 | 1,545 | 1,521 |
Current Assets | 2.6% | 1,179 | 1,149 | 1,101 | 1,059 | 1,043 | 1,090 | 956 | 938 | 1,001 | 1,098 | 1,063 | 869 | 780 | 721 | 680 | 703 | 712 | 698 | 654 | 704 | 740 |
Cash Equivalents | 19.3% | 133 | 111 | 113 | 99.00 | 114 | 205 | 144 | 145 | 232 | 351 | 384 | 176 | 105 | 81.00 | 90.00 | 104 | 111 | 117 | 124 | 147 | 175 |
Inventory | 1.1% | 395 | 391 | 368 | 355 | 333 | 302 | 269 | 258 | 241 | 226 | 210 | 218 | 229 | 212 | 195 | 205 | 197 | 189 | 173 | 180 | 176 |
Net PPE | 2.7% | 683 | 665 | 649 | 612 | 594 | 593 | 588 | 573 | 550 | 544 | 555 | 548 | 551 | 546 | 534 | 497 | 470 | 449 | 437 | 410 | 394 |
Goodwill | 0.3% | 364 | 363 | 362 | 355 | 356 | 361 | 359 | 4.00 | 109 | 243 | 243 | 238 | 235 | 23.00 | 240 | 25.00 | 215 | 215 | 214 | 20.00 | 196 |
Liabilities | -9.7% | 1,777 | 1,967 | 2,138 | 2,164 | 2,150 | 1,953 | 1,747 | 1,630 | 1,664 | 1,624 | 1,662 | 1,606 | 1,687 | 1,778 | 1,655 | 1,549 | 1,553 | 1,629 | 1,629 | 1,546 | 1,562 |
Current Liabilities | -17.1% | 884 | 1,066 | 1,236 | 1,190 | 1,167 | 971 | 764 | 634 | 652 | 621 | 583 | 527 | 541 | 846 | 725 | 627 | 619 | 690 | 770 | 760 | 774 |
LT Debt, Current | 0.0% | 75.00 | 75.00 | 75.00 | - | - | - | 75.00 | 75.00 | 125 | 125 | 50.00 | 50.00 | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.1% | 697 | 696 | 694 | 761 | 768 | 773 | 775 | 778 | 780 | 779 | 858 | 853 | - | - | 699 | - | - | - | - | - | - |
Shareholder's Equity | 30.1% | 1,094 | 841 | 609 | 476 | 457 | 640 | 690 | 755 | 748 | 703 | 633 | 441 | 273 | 108 | 178 | 203 | 172 | 52.00 | - | - | - |
Retained Earnings | 5.9% | 4,038 | 3,814 | 3,600 | 3,427 | 3,246 | 3,114 | 2,920 | 2,758 | 2,582 | 2,380 | 2,176 | 2,001 | 1,855 | 1,706 | 1,596 | 1,505 | 1,396 | 1,271 | 1,168 | 1,082 | 989 |
Additional Paid-In Capital | 1.7% | 1,515 | 1,490 | 1,463 | 1,438 | 1,420 | 1,400 | 1,377 | 1,359 | 1,339 | 1,321 | 1,295 | 1,274 | 1,247 | 1,230 | 1,214 | 1,190 | 1,171 | 1,156 | 1,138 | 1,128 | 1,109 |
Shares Outstanding | 0.1% | 83.00 | 83.00 | 83.00 | 83.00 | 84.00 | 84.00 | 85.00 | 85.00 | 85.00 | 86.00 | 85.00 | 85.00 | 85.00 | 85.00 | 85.00 | 86.00 | 86.00 | 86.00 | 86.00 | 87.00 | 87.00 |
Minority Interest | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 22.0% | 747 | 612 | 543 | 580 | 578 | 746 | 756 | 765 | 770 | 745 | 648 | 585 | 524 | 453 | 459 | 439 | 418 | 400 | 400 | 386 | 386 |
Share Based Compensation | 5.7% | 56.00 | 53.00 | 50.00 | 46.00 | 43.00 | 40.00 | 38.00 | 36.00 | 34.00 | 33.00 | 31.00 | 40.00 | 41.00 | 40.00 | 39.00 | 29.00 | 26.00 | 26.00 | 25.00 | 25.00 | 24.00 |
Cashflow From Investing | 14.3% | -165 | -193 | -195 | -190 | -190 | -310 | -292 | -264 | -234 | -84.29 | -109 | -189 | -207 | -216 | -205 | -149 | -166 | -159 | 139 | 154 | 167 |
Cashflow From Financing | -11.7% | -562 | -503 | -370 | -420 | -492 | -581 | -697 | -531 | -413 | -394 | -248 | -323 | -318 | -266 | -286 | -329 | -314 | -275 | -597 | -558 | -541 |
Buy Backs | -55.4% | 247 | 553 | 820 | 990 | 999 | 881 | 747 | 502 | 321 | 132 | 183 | 324 | 409 | 430 | 302 | 267 | 254 | 340 | 369 | 318 | 302 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Total revenue | $ 943,630 | $ 860,546 | $ 1,843,825 | $ 1,697,095 |
Cost of Revenue: | ||||
Cost of revenue | 370,780 | 346,514 | 728,004 | 684,310 |
Gross profit | 572,850 | 514,032 | 1,115,821 | 1,012,785 |
Expenses: | ||||
Sales and marketing | 140,532 | 130,257 | 288,336 | 262,549 |
General and administrative | 89,669 | 81,488 | 159,770 | 159,437 |
Research and development | 46,505 | 123,221 | 91,172 | 163,389 |
Income from operations | 296,144 | 179,066 | 576,543 | 427,410 |
Interest expense | (10,542) | (8,317) | (23,669) | (15,313) |
Interest income | 327 | 334 | 743 | 477 |
Income before provision for income taxes | 285,929 | 171,083 | 553,617 | 412,574 |
Provision for income taxes | 61,693 | 39,104 | 115,327 | 86,630 |
Net income attributable to IDEXX Laboratories, Inc. stockholders | $ 224,236 | $ 131,979 | $ 438,290 | $ 325,944 |
Earnings per Share: | ||||
Basic (in USD per share) | $ 2.70 | $ 1.57 | $ 5.28 | $ 3.87 |
Diluted (in USD per share) | $ 2.67 | $ 1.56 | $ 5.22 | $ 3.82 |
Weighted Average Shares Outstanding: | ||||
Basic (in shares) | 83,086 | 83,922 | 83,039 | 84,164 |
Diluted (in shares) | 83,983 | 84,858 | 83,980 | 85,222 |
Product revenue | ||||
Revenue: | ||||
Total revenue | $ 540,680 | $ 492,518 | $ 1,046,622 | $ 970,895 |
Cost of Revenue: | ||||
Cost of revenue | 179,999 | 167,323 | 353,609 | 329,394 |
Service revenue | ||||
Revenue: | ||||
Total revenue | 402,950 | 368,028 | 797,203 | 726,200 |
Cost of Revenue: | ||||
Cost of revenue | $ 190,781 | $ 179,191 | $ 374,395 | $ 354,916 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 132,838 | $ 112,546 |
Accounts receivable, net | 461,858 | 400,619 |
Inventories | 395,141 | 367,823 |
Other current assets | 189,188 | 220,489 |
Total current assets | 1,179,025 | 1,101,477 |
Long-Term Assets: | ||
Property and equipment, net | 683,270 | 649,474 |
Operating lease right-of-use assets | 114,148 | 118,618 |
Goodwill | 364,206 | 361,795 |
Intangible assets, net | 90,932 | 97,672 |
Other long-term assets | 439,225 | 417,729 |
Total long-term assets | 1,691,781 | 1,645,288 |
TOTAL ASSETS | 2,870,806 | 2,746,765 |
Current Liabilities: | ||
Accounts payable | 107,664 | 110,221 |
Accrued liabilities | 399,425 | 433,662 |
Credit facility | 264,000 | 579,000 |
Current portion of long-term debt | 74,991 | 74,982 |
Current portion of deferred revenue | 37,779 | 37,938 |
Total current liabilities | 883,859 | 1,235,803 |
Long-Term Liabilities: | ||
Deferred income tax liabilities | 5,568 | 8,150 |
Long-term debt, net of current portion | 696,844 | 694,387 |
Long-term deferred revenue, net of current portion | 29,054 | 30,862 |
Long-term operating lease liabilities | 97,337 | 101,239 |
Other long-term liabilities | 64,283 | 67,587 |
Total long-term liabilities | 893,086 | 902,225 |
Total liabilities | 1,776,945 | 2,138,028 |
Commitments and Contingencies (Note 16) | ||
Stockholders’ Equity: | ||
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,378 shares in 2023 and 107,193 shares in 2022; Outstanding: 83,060 shares in 2023 and 82,894 shares in 2022 | 10,738 | 10,719 |
Additional paid-in capital | 1,515,197 | 1,463,215 |
Deferred stock units: Outstanding: 59 units in 2023 and 58 units in 2022 | 5,515 | 5,182 |
Retained earnings | 4,037,819 | 3,599,529 |
Accumulated other comprehensive loss | (73,665) | (77,796) |
Treasury stock, at cost: 24,318 shares in 2023 and 24,299 shares in 2022 | (4,401,743) | (4,392,112) |
Total stockholders’ equity | 1,093,861 | 608,737 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 2,870,806 | $ 2,746,765 |